Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
The Journal of Antimicrobial Chemotherapy|May 11, 2005
Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in miceSandra Prior, Bruno Gander, Juan M Irache, et al.Human Vaccines|October 3, 2006
Development of an approach for the laboratory toxicological evaluation of Bordetella pertussis adenylate cyclase genetic toxoid constructs as multipurpose vaccinesSandra Prior, Michael J Corbel, Dorothy K L XingThe Journal of Antimicrobial Chemotherapy|April 23, 2004
Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytesSandra Prior, Bruno Gander, Concepción Lecároz, et al.Mabs|October 7, 2017
International standards for monoclonal antibodies to support pre- and post-marketing product consistency: Evaluation of a candidate international standard for the bioactivities of rituximabSandra Prior, Simon E Hufton, Bernard Fox, et al.Infection and Immunity|September 20, 2006
Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine modelGordon Y C Cheung, Dorothy Xing, Sandra Prior, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 19, 2002
In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheresSandra Prior, Bruno Gander, Natalia Blarer, et al.Microbial Pathogenesis|November 11, 2008
Functional and structural studies on different forms of the adenylate cyclase toxin of Bordetella pertussisGordon Y C Cheung, Sharon M Kelly, Thomas J Jess, et al.Current Drug Delivery|November 2, 2006
Chemical and biological factors in the control of Brucella and brucellosisCarlos Gamazo, María Concepción Lecároz, Sandra Prior, et al.Expert Opinion on Drug Delivery|November 1, 2007
Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infectionsCarlos Gamazo, Sandra Prior, María Concepción Lecároz, et al.Vaccine|May 6, 2006
Evaluation of adenyl cyclase toxin constructs from Bordetella pertussis as candidate vaccine components in an in vitro model of complement-dependent intraphagocytic killingSandra Prior, Roland A Fleck, Margaret L Gillett, et al.Pageof 2